November 5th, 2007
Bevacizumab Improves Ovarian Cancer Treatment
Bevacizumab is a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels.
Now, a new study found that bevacizumab may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
Ovarian cancer or cancer of the ovary is the fifth most common cancer in women and […]
Recent Comments